NCT06652984

Brief Summary

Introduction and aim; Low functionality of respiratory muscles is frequently observed in various diseases such as chronic obstructive pulmonary disease, cystic fibrosis, idiopathic pulmonary fibrosis, and rheumatological diseases such as ankylosing spondylitis. Strengthening the respiratory muscles is a part of the treatment in such disease groups, and it has been reported that the quality of life of patients increases with the improvement in the respiratory muscles. Stavrou et al. In a study published in 2021, they achieved an increase in VO2max and maximum respiratory power in athletes after an exercise program with the AirOFit PRO™ (AirOFit, Copenhagen, Denmark) branded mobile breathing exercise device, which they introduced as a new technology. However, there is no study yet reporting the use of this device in rheumatological diseases. The aim of this study is to investigate the effects of personalized breathing exercises with the AirOFit PRO™ (AirOFit, Copenhagen, Denmark) branded mobile breathing exercise device on respiratory muscles and functional exercise capacity, as well as on specific outcomes of the disease, in patients with ankylosing spondylitis. Hypotheses of the study; a) Hypothesis H1: Personalised breathing exercises applied with a mobile respiratory exercise device in patients with ankylosing spondylitis have a positive effect on respiratory capacity and activities of daily living in patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 22, 2024

Completed
14 days until next milestone

Study Start

First participant enrolled

November 5, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 12, 2025

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 22, 2025

Completed
Last Updated

July 8, 2025

Status Verified

July 1, 2025

Enrollment Period

6 months

First QC Date

October 18, 2024

Last Update Submit

July 4, 2025

Conditions

Keywords

rheumatological diseasesrespiratory exercisesLung capacity

Outcome Measures

Primary Outcomes (3)

  • Tidal volume

    Tidal volume; This is the amount of air breathed in or out during normal breathing. This pulmonary function test will done with a spirometry.

    At the end of the 12th week of exercise schedule

  • Vital capacity

    This is the total volume of air that can be breathed out after breathing in as much as you can. This pulmonary function test will done with a spirometry.

    At the end of the 12th week of exercise schedule

  • Forced vital capacity

    Forced vital capacity (FVC); This is the amount of air breathed out forcefully and quickly after breathing in as much as you can. This pulmonary function test will done with a spirometry.

    At the end of the 12th week of exercise schedule

Secondary Outcomes (1)

  • The Bath Ankylosing Spondylitis Functional Index

    At the end of the 12th week of exercise schedule

Study Arms (2)

Exercisers with a mobile breathing apparatus

ACTIVE COMPARATOR

The mobile device will be given to the patient for use. The exercise programme will be taught by the physiotherapist with face-to-face training before the study. The settings of the device will be started at the beginner level in breathing and exhalation exercises.

Other: Exercise 1

Pursed Lip Breathing Exercisers

ACTIVE COMPARATOR

'Pursed lip breathing' will be taught to the patients in this group. The programme will be taught by the physiotherapist with face-to-face training before the study. The patient will be taught to take a deep breath through the nose as much as he/she can and then to empty the air in the lungs in a controlled manner without applying any force by pursing the lips as if whistling.

Other: Exercise 2

Interventions

Patients were planned to complete exercise sessions 5 times a week for 12 weeks, each lasting 35 minutes per day.

Exercisers with a mobile breathing apparatus

Patients were planned to complete exercise sessions 5 times a week for 12 weeks, each lasting 35 minutes per day.

Pursed Lip Breathing Exercisers

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Volunteer for the study
  • Be over 18 years old
  • To be in the follow-up of Usak University Rheumatology outpatient clinic
  • Stability in medical treatment (keeping disease activity under control with the same medical treatment for at least 6 months)

You may not qualify if:

  • The presence of diseases that affect the function of the respiratory system (such as pneumonia, pleurisy, empyema, pneumothorax, hemothorax, hydrothorax, atelectasis, pulmonary oedema, pulmonary hypertension, emphysema, and lung cancer).
  • The presence of a regular exercise habit (regularly 3 days a week for at least six months).
  • Significant physical disability or impairment (regular use of walking aids, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Usak University

Uşak, 64200, Turkey (Türkiye)

Location

Related Publications (1)

  • Stavrou VT, Tourlakopoulos KN, Daniil Z, Gourgoulianis KI. Respiratory Muscle Strength: New Technology for Easy Assessment. Cureus. 2021 May 2;13(5):e14803. doi: 10.7759/cureus.14803.

MeSH Terms

Conditions

Spondylitis, AnkylosingDyspnea

Condition Hierarchy (Ancestors)

Axial SpondyloarthritisSpondylarthropathiesSpondylarthritisSpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesAnkylosisJoint DiseasesArthritisRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ali Y KARAHAN, MD

    Uşak University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
A blind physiotherapist will be in charge of the assessment of the outcomes of the study in all patients.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomized pretest-posttest parallel group design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2024

First Posted

October 22, 2024

Study Start

November 5, 2024

Primary Completion

May 12, 2025

Study Completion

May 22, 2025

Last Updated

July 8, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Sharing personal data must comply with the data protection principles in Turkey.

Locations